Quick Answer
Ernexa Therapeutics Inc. reported Common Stock Shares Outstanding of 7.85 million shares for the year ending 2025.
- Ernexa Therapeutics Inc. showed an increase of +129.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Ernexa Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2010 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2010 to 2025), Ernexa Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 12,828.2%.
- Historical annual values: Fiscal year 2025: 7.85 million shares | Fiscal year 2024: 3.43 million shares | Fiscal year 2024: 51.39 million shares | Fiscal year 2023: 5.41 million shares | Fiscal year 2022: 5.13 million shares | Fiscal year 2021: 2.60 million shares | Fiscal year 2020: 0 shares | Fiscal year 2019: 2.90 million shares | Fiscal year 2018: 2.88 million shares | Fiscal year 2017: 2.52 million shares | Fiscal year 2016: 2.26 million shares | Fiscal year 2016: 92.44 million shares | Fiscal year 2015: 1.85 million shares | Fiscal year 2014: 92.37 million shares | Fiscal year 2013: 78.65 million shares | Fiscal year 2012: 71.12 million shares | Fiscal year 2011: 60,927 shares | Fiscal year 2010: 60,751 shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: